A slow start for self-amplifying mRNA vaccines

By Yahoo! Finance | Oct 23, 2024 at 04:07 AM EST

The success of Arcturus Therapeutics was attributed to strategic timing and unique trial opportunities in Vietnam and Japan. The emergence of samRNA technology amid the Covid-19 pandemic offers promising advancements but faces challenges such as efficacy, safety concerns, and technical hurdles.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.